Ozempic and its weight-loss formulation Wegovy lose their legal protections in January, opening the door for generic versions of semaglutide, the active ingredient in the drugs.

Patients in Canada may have to wait longer to access generic versions of Ozempic because of continuing delays at Health Canada to process new drug submissions, according to Swiss generic drug manufacturer Sandoz.

Ozempic, the best-selling drug in Canada , and its weight-loss formulation Wegovy lose their legal protections in January, opening the door for generic versions of semaglutide, the active ingredient in the drugs.

Canada is the first major market in the world where generic semaglutide will be legal, and seven drug manufacturers have so far filed with Health Canada starting in February, 2024.

At the

See Full Page